Search

everythinglearnresearchcommunity

for

Search:↓

Immunosuppressive and anti-TNF therapies in IBD patients can increase the risk of skin cancer and cause various skin issues.

Drug repurposing can create safer, cheaper treatments by finding new uses for existing drugs.

Severe menstrual issues in PCOS women signal higher risk for heart and metabolic problems.

Severe alopecia areata may increase the risk of heart-related diseases.

When treating older patients with both heart valve disease and heart muscle disease, doctors should create personalized treatment plans that address both conditions.

Skin diseases linked to insulin resistance should be managed to prevent diabetes and reduce heart disease risk.

People with common hair loss conditions may have a higher risk of heart disease and related health issues.

IL6 is linked to higher risk of heart disease in people with a certain mouth condition.

Accurate protein modeling can help develop new treatments for prostate cancer and other diseases.

Men with androgenetic alopecia may have higher blood pressure, suggesting early screening for hypertension.

Different PCOS characteristics affect lipid profiles, increasing cardiovascular disease risk, so regular lipid screening is advised.

Oxidative stress is higher in women with PCOS, especially if they're obese, and it may increase their risk of heart disease.

Polycystic Ovary Syndrome (PCOS) affects 6%-15% of women of reproductive age, causing symptoms like acne and hair loss, and increasing the risk of type 2 diabetes and heart disease; it's managed through diet, exercise, and medications like Metformin and hormonal contraceptives.

Alopecia areata is an autoimmune disease affecting hair follicles and may harm heart health.

The update highlights that non-classic congenital adrenal hyperplasia is common in women with excess male hormones, requires specific hormone tests for diagnosis, and has various treatment options depending on age and symptoms.

People with pemphigus are more likely to have conditions like hypothyroidism, inflammatory bowel disease, and diabetes.

Cross-sex hormone therapy is important for managing gender dysphoria and requires careful monitoring and healthcare provider education.

Early hair whitening may indicate a higher risk of heart disease in young and middle-aged men.

The document concludes that managing PCOS involves treating symptoms, regulating periods, and reducing health risks, with specific medications for fertility and metabolic issues.

Androgenetic alopecia may indicate higher risk for certain diseases and mental health issues.

Women with PCOS often have metabolic issues like insulin resistance and a higher risk of diabetes and abnormal lipid levels.

Male hormones affect COVID-19 severity and certain drugs targeting these hormones could help reduce the risk.

Greek women with PCOS have a higher risk of metabolic syndrome and are more likely to be overweight compared to healthy controls.

Bioengineered skin models help reduce animal testing and advance research in cosmetics and skin disease.

Thyroid and skin autoimmune diseases share genetic and immune links, affecting both tissues.

Using topical minoxidil for baldness can cause heart problems, especially in those with heart disease.

Men with early balding should be checked for metabolic syndrome, as there's a link between the two.

Innovative methods are reducing animal testing and improving biomedical research.

Mitochondrial dysfunction links metabolic syndrome and inflammatory skin diseases, suggesting targeted therapies and lifestyle changes.

The report concludes that PCOS is mainly a condition of excess male hormones and its definition may change as new information is discovered.